Mycosis Fungoides Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Mycosis Fungoides Clinical Trials Market Report Overview
The Mycosis Fungoides clinical trial market research report provides an overview of the Mycosis Fungoides clinical trials scenario. The report provides top-line data relating to the clinical trials on Mycosis Fungoides. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Mycosis Fungoides Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Mycosis Fungoides clinical trials market are North America, Asia-Pacific, Europe, Middle East & Africa, and South & Central America. North America dominates the market.
In a country-wise analysis, as of January 2023, the US has the highest number of Mycosis Fungoides clinical trials, followed by Italy, Germany, the UK, France, Spain, Canada, China, Netherlands, and Austria.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of Mycosis Fungoides to Oncology clinical trials as of January 2023. Also, most of the clinical trials were conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Mycosis Fungoides to Oncology clinical trials as of January 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Mycosis Fungoides Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Mycosis Fungoides clinical trials market, download a free report sample
Mycosis Fungoides Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Mycosis Fungoides clinical trials market are institution, company, and the government. Out of them, institution sponsor type dominated the market.
Mycosis Fungoides Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Mycosis Fungoides clinical trials market, download a free report sample
Mycosis Fungoides Clinical Trials Market - Competitive Landscape
The leading sponsors in the Mycosis Fungoides clinical trials market are Seagen Inc, Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Johnson & Johnson, Kirin Holdings Co Ltd, Eisai Co Ltd, Merck & Co Inc, Novartis AG, Sanofi, and Soligenix Inc. Out of them, Seagen Inc has conducted the highest number of Mycosis Fungoides clinical trials.
Mycosis Fungoides Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the Mycosis Fungoides clinical trials market, download a free report sample
Mycosis Fungoides Clinical Trials Market Report Overview
Key Regions | North America, Asia-Pacific, Europe, Middle East & Africa, and South & Central America |
Key Countries | The US, Italy, Germany, the UK, France, Spain, Canada, China, Netherlands, and Austria |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | Seagen Inc, Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Johnson & Johnson, Kirin Holdings Co Ltd, Eisai Co Ltd, Merck & Co Inc, Novartis AG, Sanofi, and Soligenix Inc |
Segments Covered in the Report
Mycosis Fungoides Clinical Trials Regional Outlook (2023)
- North America
- Asia-Pacific
- Europe
- Middle East & Africa
- South & Central America
Mycosis Fungoides Clinical Trials Country Outlook (2023)
- The US
- Italy
- Germany
- The UK
- France
- Spain
- Canada
- China
- Netherlands
- Austria
Mycosis Fungoides Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Bristol-Myers Squibb Co
Takeda Pharmaceutical Co Ltd
Johnson & Johnson
Kirin Holdings Co Ltd
Eisai Co Ltd
Merck & Co Inc
Novartis AG
Sanofi
Soligenix Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the Mycosis Fungoides clinical trials market?
The key regions in the Mycosis Fungoides clinical trials market are North America, Asia-Pacific, Europe, Middle East & Africa, and South & Central America, among others.
-
Which are the key countries in the Mycosis Fungoides clinical trials market?
The key countries in the Mycosis Fungoides clinical trials market are the US, Italy, Germany, the UK, France, Spain, Canada, China, Netherlands, and Austria.
-
Who are the key sponsor types in the Mycosis Fungoides clinical trials market?
The key sponsor types in the Mycosis Fungoides clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the Mycosis Fungoides clinical trials market?
The leading sponsors in the Mycosis Fungoides clinical trials market are Seagen Inc, Bristol-Myers Squibb Co, Takeda Pharmaceutical Co Ltd, Johnson & Johnson, Kirin Holdings Co Ltd, Eisai Co Ltd, Merck & Co Inc, Novartis AG, Sanofi, and Soligenix Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.